TITLE

Tuberculosis Management by Private Practitioners in Mumbai, India: Has Anything Changed in Two Decades?

AUTHOR(S)
Udwadia, Zarir F.; Pinto, Lancelot M.; Uplekar, Mukund W.
PUB. DATE
August 2010
SOURCE
PLoS ONE;2010, Vol. 5 Issue 8, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Setting: Mumbai, India. A study conducted in Mumbai two decades ago revealed the extent of inappropriate tuberculosis (TB) management practices of private practitioners. Over the years, India's national TB programme has made significant progress in TB control. Efforts to engage private practitioners have also been made with several successful documented public-private mix initiatives in place. Objective: To study prescribing practices of private practitioners in the treatment of tuberculosis, two decades after a similar study conducted in the same geographical area revealed dismal results. Methods: Survey questionnaire administered to practicing general practitioners attending a continuing medical education programme. Results: The participating practitioners had never been approached or oriented by the local TB programme. Only 6 of the 106 respondents wrote a prescription with a correct drug regimen. 106 doctors prescribed 63 different drug regimens. There was tendency to over treat with more drugs for longer durations. Only 3 of the 106 respondents could write an appropriate prescription for treatment of multidrug-resistant TB. Conclusions: With a vast majority of private practitioners unable to provide a correct prescription for treating TB and not approached by the national TB programme, little seems to have changed over the years. Strategies to control TB through public sector health services will have little impact if inappropriate management of TB patients in private clinics continues unabated. Large scale implementation of public-private mix approaches should be a top priority for the programme. Ignoring the private sector could worsen the epidemic of multidrug-resistant and extensively drug-resistant forms of TB.
ACCESSION #
56576548

 

Related Articles

  • MDR-TB being tackled efficiently.  // BioSpectrum;Apr2013, Vol. 11 Issue 4, p16 

    The article discusses the results of the survey conducted by the Union Health Ministry which shows that the 5, 962 detected and treated cases of multi drug resistant tuberculosis (MDR-TB) has increased.

  • Multidrug-Resistant Tuberculosis With Fluoroquinolone Resistance: Sinister Association With Other Drugs and Ominous Implications for Treatment. Ajbani, Kanchan; Nikam, Chaitali; Shetty, Anjali; Soman, Rajeev; Rodrigues, Camilla // Clinical Infectious Diseases;Jul2014, Vol. 59 Issue 1, p138 

    The article reports the study on the challenges faced in the control and management of the disease due to the emergence of drug-resistant tuberculosis (DR). Topics discussed include lack of quality evidence in clinical and operational management of DR tuberculosis, individualized drug...

  • Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for India. Atre, Sachin R; Murray, Megan B // Journal of Public Health Policy;Aug2016, Vol. 37 Issue 3, p277 

    Multidrug-resistant tuberculosis (MDR-TB) challenges TB control efforts because of delays in diagnosis plus its long-term treatment which has toxic effects. Of TB high-incidence countries, India carries the highest burden of MDR-TB cases. We describe policy issues in India concerning MDR-TB...

  • Significant Clinical Impact of a Rapid Molecular Diagnostic Test (Genotype MTBDRplus Assay) to Detect Multidrug-Resistant Tuberculosis. Kipiani, Maia; Mirtskhulava, Veriko; Tukvadze, Nestani; Magee, Matthew; Blumberg, Henry M.; Kempker, Russell R. // Clinical Infectious Diseases;Dec2014, Vol. 59 Issue 11, p1559 

    Implementation of a rapid molecular diagnostic for the detection of multidrug-resistant tuberculosis (MDR-TB) led to decreased times to initiation of second-line drug treatment, culture conversion, and decreased the length of time MDR-TB patients were hospitalized on drug-susceptible TB...

  • POST-ELECTION U.S-INDIA FOREIGN POLICY STRATEGY SHOULD START WITH TUBERCULOSIS. JONES, KERMIT L.; SINGH, PRABHJOT // Diplomatic Courier;Jul2014, Vol. 8 Issue 4, p40 

    The article discusses the need for the U.S.-India diplomatic relationship to collaborate on combating drug resistant tuberculosis (TB) at the top of their foreign policy agenda. It mentions the World Health Organization's designation of India as high burden country, with an estimated 2.8 million...

  • The making of a public health problem: multi-drug resistant tuberculosis in India. Engel, Nora C // Health Policy & Planning;Jul2013, Vol. 28 Issue 4, p375 

    This paper examines how actors construct the public problem of multi-drug resistant tuberculosis (MDR-TB) in India. MDR-TB has been framed by the World Health Organization as a pressing, global public health problem. The responses to MDR-TB are complicated as treatment takes longer and is more...

  • Multidrug resistant tuberculosis treatment in India. Prasad, Rajendra; Gupta, Nikhil; Balasubramanian, Viswesvaran; Singh, Abhijeet // Drug Discoveries & Therapeutics;Jun2015, Vol. 9 Issue 3, p156 

    Multidrug-resistant tuberculosis (MDR-TB) is posing a major public health threat as well as a big challenge to global efforts of tuberculosis control. The management of MDR-TB patients is difficult, expensive, challenging and quite often leads to treatment failure. To avoid further transmission,...

  • Effects of Treatment Interruption Patterns on Treatment Success Among Patients With Multidrug-Resistant Tuberculosis in Armenia and Abkhazia. Bastard, Mathieu; Sanchez-Padilla, Elisabeth; Hewison, Cathy; Hayrapetyan, Armen; Khurkhumal, Shazina; Varaine, Francis; Bonnet, Maryline // Journal of Infectious Diseases;May2015, Vol. 211 Issue 10, p1607 

    Background. The success of the current treatment regimen for multidrug-resistant (MDR) tuberculosis is poor partly owing to a high default rate. Many studies have explored predictors of poor outcomes, but very few have assessed the effects of treatment interruptions on treatment outcomes for MDR...

  • Efficacy and effect of free treatment on multidrug-resistant tuberculosis. QING ZHANG; ZHEYUAN WU; ZURONG ZHANG; WEI SHA; XIN SHEN; HEPING XIAO // Experimental & Therapeutic Medicine;Mar2016, Vol. 11 Issue 3, p777 

    Multidrug-resistant tuberculosis (MDR-TB) is a serious public health and social issue. It pertains to the type of tuberculosis that is resistant simultaneously to isoniazid and rifampicin. MDR-TB has a high mortality and is expensive to treat. The aim of the present study was to examine the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics